Literature DB >> 19064060

Complications of en bloc resections in the spine.

Stefano Bandiera1, Stefano Boriani, Rakesh Donthineni, L Amendola, Michele Cappuccio, Alessandro Gasbarrini.   

Abstract

Morbidity of surgical procedures for spine tumors is expected to be worse than for other conditions. This is particularly true for en bloc resections, a technically demanding procedure. En bloc resections can help improve the prognosis of aggressive benign and malignant tumors in the spine, but the related morbidity is high and sometimes fatal. Reoperations have higher risks because of dissection through scar/fibrosis from previous surgeries and possibly from radiation. Careful planning for treatment is mandatory, and if the surgeon is unsure, referral to a specialty center is necessary.

Entities:  

Mesh：

Year:  2009        PMID： 19064060     DOI： 10.1016/j.ocl.2008.10.002

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN： 0030-5898            Impact factor:   2.472


  15 in total

1.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

2.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

Review 3.  Variables affecting functional improvement in chordoma patients admitted to an inpatient rehabilitation facility: A retrospective review.

Authors:  Sasha E Knowlton; Richard Goldstein; Kevin C O'Connor; Joseph Schwab; Francis Hornicek; Ross Zafonte
Journal:  J Spinal Cord Med       Date:  2017-05-02       Impact factor: 1.985

Review 4.  Aneurysmal bone cyst of the spine treated by concentrated bone marrow: clinical cases and review of the literature.

Authors:  Giovanni Barbanti-Brodano; Marco Girolami; Riccardo Ghermandi; Silvia Terzi; Alessandro Gasbarrini; Stefano Bandiera; Stefano Boriani
Journal:  Eur Spine J       Date:  2017-02-06       Impact factor: 3.134

5.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

6.  Metastatic epidural spinal cord compression: does timing of surgery influence the chance of neurological recovery? An observational case-control study.

Authors:  Valerio Pipola; Silvia Terzi; Giuseppe Tedesco; Stefano Bandiera; Giovanni Barbanti Bròdano; Riccardo Ghermandi; Gisberto Evangelisti; Marco Girolami; Alessandro Gasbarrini
Journal:  Support Care Cancer       Date:  2018-03-30       Impact factor: 3.603

7.  Chondrosarcoma of the mobile spine and sacrum.

Authors:  Ryan M Stuckey; Rex A W Marco
Journal:  Sarcoma       Date:  2011-03-03

Review 8.  En Bloc Resection of Solitary Functional Secreting Spinal Metastasis.

Authors:  C Rory Goodwin; Michelle J Clarke; Ziya L Gokaslan; Charles Fisher; Ilya Laufer; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-07-16

9.  Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: A case report.

Authors:  Toshiyuki Nakazawa; Gen Inoue; Takayuki Imura; Masayuki Miyagi; Wataru Saito; Takanori Namba; Eiki Shirasawa; Kentaro Uchida; Naonobu Takahira; Masashi Takaso
Journal:  Int J Surg Case Rep       Date:  2016-05-10

10.  Spondylectomy for Giant Cell Tumor After Denosumab Therapy.

Authors:  Rodrigo Alves de Carvalho Cavalcante; Rômulo Alberto Silva Marques; Vinicius Gonçalves dos Santos; Eduardo Sabino; Ailton Cabral Fraga; Vladimir Arruda Zaccariotti; Joao Batista Arruda; Yvens Barbosa Fernandes
Journal:  Spine (Phila Pa 1976)       Date:  2016-02       Impact factor: 3.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.